Effective February 13, 2013, the Board of Directors of Myrexis, Inc. appointed Steven D. Scheiwe and Michael C. Pearce to the Board. Mr. Scheiwe was appointed as a Class I director with a term expiring at the 2013 annual meeting of stockholders. Mr. Pearce was appointed as a Class III director with a term expiring at the 2012 annual meeting of stockholders. Mr. Scheiwe has been the President of Ontrac Advisors, Inc. and Mr. Pearce has served as Chairman of Pernix Therapeutics Holdings.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0105 USD | 0.00% | 0.00% | +61.54% |
1st Jan change | Capi. | |
---|---|---|
+61.54% | 362K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.79% | 22.15B | |
-17.37% | 21.02B | |
-8.91% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MYRX Stock
- News Myrexis, Inc.
- Myrexis, Inc. Announces New Board Appointments, Effective February 13, 2013